Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem, 19504 [2020-07277]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
19504
Federal Register / Vol. 85, No. 67 / Tuesday, April 7, 2020 / Notices
based filings or paper copies of any
electronic filings will be accepted until
further notice.
Written submissions.— Parties that
have requested to participate in the
written proceedings held in lieu of an
in-person staff conference may submit
opening remarks limited to five pages
and witness testimony (in the form of
certified affidavits) limited to 50 pages
no later than April 17, 2020. As
provided in sections 201.8 and 207.15 of
the Commission’s rules, any person may
submit to the Commission on or before
April 27, 2020, a written brief
containing information and arguments
pertinent to the subject matter of the
investigations, including responses to
staff questions. All written submissions
must conform with the provisions of
section 201.8 of the Commission’s rules;
any submissions that contain BPI must
also conform with the requirements of
sections 201.6, 207.3, and 207.7 of the
Commission’s rules. The Commission’s
Handbook on Filing Procedures,
available on the Commission’s website
at https://www.usitc.gov/documents/
handbook_on_filing_procedures.pdf,
elaborates upon the Commission’s
procedures with respect to filings.
Please note the Secretary’s Office will
accept only electronic filings during this
time. Filings must be made through the
Commission’s Electronic Document
Information System (EDIS, https://
edis.usitc.gov). No in-person paperbased filings or paper copies of any
electronic filings will be accepted until
further notice.
In accordance with sections 201.16(c)
and 207.3 of the rules, each document
filed by a party to the investigations
must be served on all other parties to
the investigations (as identified by
either the public or BPI service list), and
a certificate of service must be timely
filed. The Secretary will not accept a
document for filing without a certificate
of service.
Certification.—Pursuant to section
207.3 of the Commission’s rules, any
person submitting information to the
Commission in connection with these
investigations must certify that the
information is accurate and complete to
the best of the submitter’s knowledge. In
making the certification, the submitter
will acknowledge that any information
that it submits to the Commission
during these investigations may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of these or related investigations or
reviews, or (b) in internal investigations,
audits, reviews, and evaluations relating
to the programs, personnel, and
VerDate Sep<11>2014
18:22 Apr 06, 2020
Jkt 250001
operations of the Commission including
under 5 U.S.C. Appendix 3; or (ii) by
U.S. government employees and
contract personnel, solely for
cybersecurity purposes. All contract
personnel will sign appropriate
nondisclosure agreements.
Authority: These investigations are
being conducted under authority of title
VII of the Tariff Act of 1930; this notice
is published pursuant to section 207.12
of the Commission’s rules.
By order of the Commission.
Issued: April 1, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020–07207 Filed 4–6–20; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–619]
Bulk Manufacturer of Controlled
Substances Application: American
Radiolabeled Chem
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before June 8, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on March 7, 2020,
American Radiolabeled Chem, 101 Arc
Drive, Saint Louis, Missouri 63146,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Gamma Hydroxybutyric Acid.
Ibogaine ....................
Lysergic acid
diethylamide.
Tetrahydrocannabinols.
Dimethyltryptamine ...
1-[1-(2-Thienyl)cyclo
hexyl]piperidine.
Dihydromorphine ......
Heroin .......................
Normorphine .............
Amphetamine ...........
PO 00000
Frm 00083
Fmt 4703
Drug
code
Schedule
2010
I
7260
7315
I
I
7370
I
7435
7470
I
I
9145
9200
9313
1100
I
I
I
II
Sfmt 4703
Controlled substance
Methamphetamine ....
Amobarbital ..............
Phencyclidine ...........
Phenylacetone ..........
Cocaine ....................
Codeine ....................
Dihydrocodeine .........
Oxycodone ...............
Hydromorphone ........
Ecgonine ...................
Hydrocodone ............
Meperidine ................
Metazocine ...............
Methadone ................
Dextropropoxyphene,
bulk (non-dosage
forms).
Morphine ...................
Oripavine ..................
Thebaine ...................
Oxymorphone ...........
Phenazocine .............
Carfentanil ................
Fentanyl ....................
Drug
code
Schedule
1105
2125
7471
8501
9041
9050
9120
9143
9150
9180
9193
9230
9240
9250
9273
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
9300
9330
9333
9652
9715
9743
9801
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the above-listed
controlled substances as radiolabeled
compounds for biochemical research.
No other activities for these drug codes
are authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–07277 Filed 4–6–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–618]
Importer of Controlled Substances
Application: Almac Clinical Services
Incorp (ACSI)
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 7, 2020. Such persons
may also file a written request for a
hearing on the application on or before
May 7, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
DATES:
E:\FR\FM\07APN1.SGM
07APN1
]]>Agencies
[Federal Register Volume 85, Number 67 (Tuesday, April 7, 2020)]
[Notices]
[Page 19504]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-07277]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-619]
Bulk Manufacturer of Controlled Substances Application: American
Radiolabeled Chem
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before June 8, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on March 7, 2020, American Radiolabeled Chem, 101 Arc
Drive, Saint Louis, Missouri 63146, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid............. 2010 I
Ibogaine.............................. 7260 I
Lysergic acid diethylamide............ 7315 I
Tetrahydrocannabinols................. 7370 I
Dimethyltryptamine.................... 7435 I
1-[1-(2-Thienyl)cyclohexyl]piperidine. 7470 I
Dihydromorphine....................... 9145 I
Heroin................................ 9200 I
Normorphine........................... 9313 I
Amphetamine........................... 1100 II
Methamphetamine....................... 1105 II
Amobarbital........................... 2125 II
Phencyclidine......................... 7471 II
Phenylacetone......................... 8501 II
Cocaine............................... 9041 II
Codeine............................... 9050 II
Dihydrocodeine........................ 9120 II
Oxycodone............................. 9143 II
Hydromorphone......................... 9150 II
Ecgonine.............................. 9180 II
Hydrocodone........................... 9193 II
Meperidine............................ 9230 II
Metazocine............................ 9240 II
Methadone............................. 9250 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine.............................. 9300 II
Oripavine............................. 9330 II
Thebaine.............................. 9333 II
Oxymorphone........................... 9652 II
Phenazocine........................... 9715 II
Carfentanil........................... 9743 II
Fentanyl.............................. 9801 II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the above-
listed controlled substances as radiolabeled compounds for biochemical
research. No other activities for these drug codes are authorized for
this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-07277 Filed 4-6-20; 8:45 am]
BILLING CODE 4410-09-P
